Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04707066 · ClinicalTrials.gov registry record · NA
Comprehensive Adaptive Multisite Prevention of University Student Suicide
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 227
- Enrollment target
NCT04707066: Completed NA study, sponsored by Duke University.
NCT04707066 is a NA study that has completed, run by Duke University. The registered enrollment target is 227 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04707066, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 227 participants
- Enrollment target
Study Summary
Suicide is the 2nd leading cause of death among college students and suicidal ideation and suicide-related behaviors are a frequent presenting problem at college counseling centers (CCCs), which are overburdened. Studies show that some students respond rapidly to treatment, whereas others require considerably more resources. Evidence-based adaptive treatment strategies (ATSs) are needed to address this heterogeneity in responsivity and complexity. ATSs individualize treatment via decision rules specifying how the type and intensity of an intervention can be sequenced based on risk factors, response, or compliance. The purpose of this multisite study is to investigate the effectiveness of four adaptive treatment strategies (ATSs) to treat college students who report suicidal ideation when first seeking services at their college counseling center This multisite study will enroll moderately to severely suicidal college students in the "emerging adulthood" phase (ages 18-25) seeking services at CCCs. This Sequential Multi-Assignment Randomized Trial (SMART) will have two stages of intervention. In Stage 1, 700 participants from four CCCs will be randomized to 4-8 weeks of: 1) a suicide-focused treatment - Collaborative Assessment and Management of Suicidality (CAMS) or 2) Treatment as Usual (TAU). Sufficient responders to either intervention will discontinue services/be stepped down. Non-responders will be re-randomized to one of two Stage 2 higher intensity/dosage intervention options for an additional 4-16 weeks: 1) CAMS (either continued or administered for the first time) or 2) Comprehensive Dialectical Behavior Therapy (DBT), which includes individual therapy, skills group, and phone/text coaching for the clients and peer consultation for the counselors.
Primary Outcome
Change in score of CAMS Scale for Suicidal Ideation (SSI). This is a 19 question measure, each rated from 0-2. Total score is from 0-38, with a higher score indicating greater suicidality concern.
Interventions
- BEHAVIORAL Treatment As Usual (TAU)
- BEHAVIORAL Collaborative Assessment and Management of Suicidality (CAMS) - Phase 1
- BEHAVIORAL Dialectical Behavior Therapy (DBT) - Phase 2
- BEHAVIORAL Maintenance/Monitoring - Phase 2
- BEHAVIORAL Collaborative Assessment and Management of Suicidality (CAMS) - Phase 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2022-10-25 |
| Est. Completion | 2024-11-19 |
| Phase | NA |
What the finished NCT04707066 record still lists
NCT04707066 is an interventional study that assigns participants to a tested intervention. The registered 227 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 5 interventions - of which Treatment As Usual (TAU) is the first listed.
NCT04707066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04707066 about?
NCT04707066 is a clinical study titled "Comprehensive Adaptive Multisite Prevention of University Student Suicide". Suicide is the 2nd leading cause of death among college students and suicidal ideation and suicide-related behaviors are a frequent presenting problem at college counseling centers (CCCs), which are overburdened. Studies show that some students respond rapidly to treatment, whereas others require co...
What is the current status of trial NCT04707066?
This trial is currently completed. It is a NA study. The enrollment target is 227 participants. The study started on 2022-10-25. Estimated completion is 2024-11-19.
What interventions are being tested in trial NCT04707066?
The interventions under investigation include: Treatment As Usual (TAU) (BEHAVIORAL), Collaborative Assessment and Management of Suicidality (CAMS) - Phase 1 (BEHAVIORAL), Dialectical Behavior Therapy (DBT) - Phase 2 (BEHAVIORAL), Maintenance/Monitoring - Phase 2 (BEHAVIORAL), Collaborative Assessment and Management of Suicidality (CAMS) - Phase 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT04707066?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04707066's enrollment target sits among peer trials
227 471st of 2000 higher than 1,530 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04751409 · 227 participants · Phase 2
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
- NCT05742360 · 227 participants
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
- NCT05890352 · 227 participants · Phase 2
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI